SCHOTT Pharma AG & Co. KGaA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A3ENQ51
EUR
14.70
-0.3 (-2.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Sep'24
Dec'23
Sep'23
Dec'22
Sep'22
Sep'21
Sep'20
Net Sales
957.09
899.00
898.60
821.00
821.14
648.67
584.23
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
957.09
899.00
898.60
821.00
821.14
648.67
584.23
Raw Material Cost
636.13
0.00
583.53
0.00
525.88
422.50
388.22
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1.65
0.00
1.42
0.00
1.16
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.19
0.00
6.94
0.00
2.43
1.45
1.74
Selling and Distribution Expenses
124.48
0.00
122.09
0.00
110.21
92.01
89.23
Other Expenses
0.94
0.00
1.85
0.00
1.99
2.08
2.18
Total Expenditure (Excl Depreciation)
784.86
0.00
732.44
0.00
659.62
536.80
501.03
Operating Profit (PBDIT) excl Other Income
172.2
899
166.20000000000002
821
161.5
111.89999999999999
83.2
Other Income
13.66
0.00
10.72
0.00
-2.44
0.58
8.90
Operating Profit (PBDIT)
249.65
0.00
221.94
0.00
214.66
147.47
125.21
Interest
13.19
0.00
6.94
0.00
2.43
1.45
1.74
Exceptional Items
0.00
0.00
5.71
0.00
-11.57
0.00
0.00
Gross Profit (PBDT)
320.96
0.00
315.07
0.00
295.26
226.17
196.01
Depreciation
64.98
0.00
46.65
0.00
55.36
36.44
33.73
Profit Before Tax
171.48
0.00
174.06
0.00
145.30
109.58
89.74
Tax
33.63
0.00
33.87
0.00
32.44
22.12
17.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
149.69
152.00
151.84
0.00
125.38
100.75
77.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
149.69
152.00
151.84
0.00
125.38
100.75
77.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.66
0.00
0.09
0.00
0.47
0.41
0.15
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
150.34
152.00
151.93
0.00
125.85
101.17
77.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
0.0
1.0
0.0
1.0
1.0
1.0
Reserves
790.41
0.00
690.43
0.00
707.28
417.96
314.52
Earnings per share (EPS)
0.99
0.0
1.01
0.0
0.83
0.67
0.51
Diluted Earnings per share
0.99
0.0
1.01
0.0
0.83
0.67
0.51
Operating Profit Margin (Excl OI)
17.87%
0.0%
18.31%
0.0%
19.7%
17.03%
14.14%
Gross Profit Margin
24.71%
0.0%
24.56%
0.0%
24.44%
22.51%
21.13%
PAT Margin
15.64%
16.91%
16.9%
0.0%
15.27%
15.53%
13.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Sep 2024 is 6.51%

stock-summary

Consolidate Net Profit

YoY Growth in year ended Sep 2024 is -1.05%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Sep 2024 is 11.74%

stock-summary

Interest

YoY Growth in year ended Sep 2024 is 91.30%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Sep 2024 has fallen from Sep 2023

Compare Annual Results Of SCHOTT Pharma AG & Co. KGaA With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
957.09
0
957.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
957.09
0
957.09
Raw Material Cost
636.13
0
636.13
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1.65
0
1.65
Power Cost
0
0
0.00
Manufacturing Expenses
13.19
0
13.19
Selling and Distribution Expenses
124.48
0
124.48
Other Expenses
0.94
0.00
0.94
Total Expenditure (Excl Depreciation)
784.86
0
784.86
Operating Profit (PBDIT) excl Other Income
172.23
0.00
172.23
Other Income
13.66
0
13.66
Operating Profit (PBDIT)
249.65
0
249.65
Interest
13.19
0
13.19
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
320.96
0
320.96
Depreciation
64.98
0
64.98
Profit Before Tax
171.48
0
171.48
Tax
33.63
0
33.63
Provisions and contingencies
0
0
0.00
Profit After Tax
149.69
0
149.69
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
149.69
0
149.69
Share in Profit of Associates
0
0
0.00
Minority Interest
0.66
0
0.66
Other related items
0.00
0.00
0.00
Consolidated Net Profit
150.34
0
150.34
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
790.41
0
790.41
Earnings per share (EPS)
0.99
0
0.99
Diluted Earnings per share
0.99
0
0.99
Operating Profit Margin (Excl OI)
17.87%
0%
0.00
17.87%
Gross Profit Margin
24.71%
0%
0.00
24.71%
PAT Margin
15.64%
0%
0.00
15.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 95.71 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 6.51%

Annual - Consolidate Net Profit
Consolidate Net Profit 15.03 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is -1.05%

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.60 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 11.74%

Annual - Interest
Interest 1.32 Million
in Sep 2024

Figures in Million
stock-summary

YoY Growth in year ended Sep 2024 is 91.30%

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.87%
in Sep 2024

Figures in %
stock-summary

YoY Growth in year ended Sep 2024 has fallen from Sep 2023